Lv3
274 积分 2023-09-27 加入
Circulating tumour DNA in early stage and locally advanced NSCLC: ready for clinical implementation?
1个月前
已完结
Tumor evolution: signaling pathways, molecular mechanisms and therapeutic targets
1个月前
已完结
Comparison of circulating tumor DNA assays for molecular residual disease detection in non-small cell lung cancer
1个月前
已完结
Towards biomarker-driven therapies for urothelial carcinoma
2个月前
已完结
Immunophenotypic spectrum and mutational landscape of EBV‐positive inflammatory follicular dendritic cell sarcoma
2个月前
已完结
Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis
2个月前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
2个月前
已完结
Health-related quality of life with first- vs second-line CDK4/6 inhibitor use in advanced breast cancer: results from the SONIA trial
2个月前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer: circulating tumor DNA analysis of a randomized phase 3 trial
2个月前
已完结
Immunotherapy approaches for malignant pleural mesothelioma
2个月前
已完结
皖公网安备34019202002308
